Literature DB >> 21417995

Telomerase: structure, functions, and activity regulation.

M I Zvereva1, D M Shcherbakova, O A Dontsova.   

Abstract

Telomerase is the enzyme responsible for maintenance of the length of telomeres by addition of guanine-rich repetitive sequences. Telomerase activity is exhibited in gametes and stem and tumor cells. In human somatic cells proliferation potential is strictly limited and senescence follows approximately 50-70 cell divisions. In most tumor cells, on the contrary, replication potential is unlimited. The key role in this process of the system of the telomere length maintenance with involvement of telomerase is still poorly studied. No doubt, DNA polymerase is not capable to completely copy DNA at the very ends of chromosomes; therefore, approximately 50 nucleotides are lost during each cell cycle, which results in gradual telomere length shortening. Critically short telomeres cause senescence, following crisis, and cell death. However, in tumor cells the system of telomere length maintenance is activated. Besides catalytic telomere elongation, independent telomerase functions can be also involved in cell cycle regulation. Inhibition of the telomerase catalytic function and resulting cessation of telomere length maintenance will help in restriction of tumor cell replication potential. On the other hand, formation of temporarily active enzyme via its intracellular activation or due to stimulation of expression of telomerase components will result in telomerase activation and telomere elongation that can be used for correction of degenerative changes. Data on telomerase structure and function are summarized in this review, and they are compared for evolutionarily remote organisms. Problems of telomerase activity measurement and modulation by enzyme inhibitors or activators are considered as well.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21417995     DOI: 10.1134/s0006297910130055

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  44 in total

1.  Identification of GdRFC1 as a novel regulator of telomerase in Giardia duodenalis.

Authors:  Xianhe Li; Nan Zhang; Na Wu; Jianhua Li; Ju Yang; Yanhui Yu; Jingtong Zheng; Xin Li; Xiaocen Wang; Pengtao Gong; Xichen Zhang
Journal:  Parasitol Res       Date:  2020-02-19       Impact factor: 2.289

Review 2.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

3.  DNA methylation of genes of the main components of the telomerase complex in Danio rerio.

Authors:  E V Belova; A E Kozlov; O S Shubernetskaya; M I Zvereva; O V Shpanchenko; O A Dontsova
Journal:  Dokl Biochem Biophys       Date:  2015-10-31       Impact factor: 0.788

4.  Zscan4 interacts directly with human Rap1 in cancer cells regardless of telomerase status.

Authors:  Kyungwoo Lee; Lauren S Gollahon
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

5.  Intestinal epithelial regeneration: active versus reserve stem cells and plasticity mechanisms.

Authors:  Soham Karmakar; Lu Deng; Xi C He; Linheng Li
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

6.  Peripheral Blood Leukocyte Telomere Length and Endometriosis.

Authors:  Naoko Sasamoto; Jennifer Yland; Allison F Vitonis; Daniel W Cramer; Linda J Titus; Immaculata De Vivo; Stacey A Missmer; Kathryn L Terry
Journal:  Reprod Sci       Date:  2020-06-23       Impact factor: 3.060

7.  A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.

Authors:  Yi Shi; Lin Sun; Ge Chen; Dongyan Zheng; Li Li; Wanguo Wei
Journal:  Target Oncol       Date:  2015-04-29       Impact factor: 4.493

8.  Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.

Authors:  Z Qi; R Mi
Journal:  Cancer Gene Ther       Date:  2016-01-08       Impact factor: 5.987

9.  Selected telomere length changes and aberrant three-dimensional nuclear telomere organization during fast-onset mouse plasmacytomas.

Authors:  Alexandra Kuzyk; Sabine Mai
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

10.  Changes in telomere length and serum neurofilament light chain levels in female patients with chronic insomnia disorder.

Authors:  Chong-Yang Ren; Pei-Pei Liu; Jing Li; Ya-Qiang Li; Li-Jun Zhang; Gui-Hai Chen; Fang-Yi Dong; Dong Hu; Mei Zhang
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.